4:15 PM ET
8-K
Regulatory Approval
TriSalus Life Sciences Regulatory Approval
TriSalus Life Sciences received FDA 510(k) clearance for its TriNav Advance device, an expansion of its Pressure-Enabled Drug Delivery (PEDD) portfolio. The device is designed to access small, distal vessels during liver embolization procedures and the company expects to commence commercialization in the coming weeks.